Concurrent Chemoradiotherapy with Docetaxel, Cisplatin, and 5-fluorouracil Improves Survival of Patients with Advanced Esophageal Cancer Compared with Conventional Concurrent Chemoradiotherapy with Cisplatin and 5-fluorouracil.

Tamaki, Yukihisa; Hieda, Yoko; Nakajima, Masanobu; Kitajima, Kazuhiro; Yoshida, Rika; Yoshizako, Takeshi; Ue, Atsushi; Tokudo, Mutsumi; Hirahara, Noriyuki; Moriyama, Ichiro; Kato, Hiroyuki; Inomata, Taisuke

Tamaki, Yukihisa; Hieda, Yoko; Nakajima, Masanobu; Kitajima, Kazuhiro; Yoshida, Rika; Yoshizako, Takeshi; Ue, Atsushi; Tokudo, Mutsumi; Hirahara, Noriyuki; Moriyama, Ichiro; Kato, Hiroyuki; Inomata, Taisuke.

Afiliación

Tamaki Y; Department of Radiation Oncology, Shimane University Faculty of Medicine.
Hieda Y; Department of Radiation Oncology, Shimane University Faculty of Medicine.
Nakajima M; Department of Surgery I, Dokkyo Medical University.
Kitajima K; Department of Radiology, Division of Nuclear Medicine and PET Center, Hyogo College of Medicine.
Yoshida R; Department of Radiology, Shimane University Faculty of Medicine.
Yoshizako T; Department of Radiology, Shimane University Faculty of Medicine.
Ue A; Department of Radiation Oncology, Shimane University Faculty of Medicine.
Tokudo M; Department of Radiation Oncology, Shimane University Faculty of Medicine.
Hirahara N; Department of Digestive and General Surgery, Shimane University Faculty of Medicine.
Moriyama I; Division of Cancer Center, Shimane University Hospital.
Kato H; Department of Surgery I, Dokkyo Medical University.
Inomata T; Department of Radiation Oncology, Shimane University Faculty of Medicine.